These FAQs were originally published in April, 2020. This study is now closed.
To build a body of information that can support the management of people with type 1 diabetes who have confirmed suspected COVID-19 illness.
PIs for this study are Drs. Osagie Ebekozien (T1D Exchange); G. Todd Alonso (Barbara Davis Center); and Mary Pat Gallagher (NYU Langone Health).
T1D Healthcare Providers or designated staff can submit relevant cases by using this secure survey link, here. (survey now closed)
10-15 minutes.
No. All the data is anonymous and there is no patient identifier used.
NOTE: This study is now closed.
Short answer No as the T1D Exchange has secured a central IRB waiver. As the coordinating center, we received a Non-Human Subjects Research determination from the Western Institutional Review Board for a central IRB. Please visit this Trello page to see our protocol and WIRB determination letter. Other centers have also received a waiver and allowed to participate in the study. However, if your institution requires a local approval before you can participate, you are welcome to use this language in their internal IRB, if institutions require that.
This is simply surveillance data capture.
No. This is only tracking people with type 1 diabetes (T1D).
Everyone’s contributions make it more relevant and helpful for diabetes policy settings related to health outcomes for people with type 1 diabetes with COVID-19. As of April 8, 2020, 35 hospitals have signed up to join the study. You can also join by entering case data into the survey or emailing qi@t1dexchange.org to express your interest.
Please designate one person from your clinic to contribute data.
Please share whenever you have a confirmed or suspected case of COVID 19 in a patient with Type 1 diabetes.
Both. Please share data from all patients with COVID-19 or COVID-19 symptoms from past months (February 2020 – present) and any new relevant case in the future.
Yes, we can also share with you an excel spreadsheet you can return to us securely with multiple case reports. Please email qi@t1dexchange.org if you prefer this option.
Patients don’t need to have a diagnosis. We are collecting information from suspected cases presenting with COVID like illness as well.
We will also share insights and aggregate data with you regularly to inform immediate improvement and care.
You do not need to see the patient in person. Tracking remotely managed patients counts.
Share your question with us at QI@T1DExchange.org and we will respond ASAP.